Pentoxifylline does not prevent microvascular injury in normotensive, septic rats
- 1 January 1995
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 23 (1) , 119-124
- https://doi.org/10.1097/00003246-199501000-00020
Abstract
To determine if treatment with pentoxifylline would decrease the tissue injury that occurs in a normotensive model of sepsis. Random assignment to control, cecal ligation-perforation, or cecal ligation-perforation plus pentoxifylline groups for a 24-hr study. Animal laboratory. Male Sprague-Dawley rats. Sepsis was induced by cecal ligation-perforation with aggressive fluid resuscitation (normal saline 10 mL/kg/hr). Pentoxifylline was administered as a 2-mg/kg bolus, followed by a continuous infusion of 6 mg/kg/hr. Compared with controls, rats in the cecal ligation-perforation group had an increased heart rate (432 +/- 12 vs. 399 +/- 10 beats/min) and respiratory rate (129 +/- 6 vs. 94 +/- 7 breaths/min). Blood pressure was slightly decreased (104 +/- 4 vs. 125 +/- 5 mm Hg), while cardiac index was not significantly different (50.1 +/- 5.7 vs. 40.7 +/- 3.9 mL/min/100 g). Blood pressure (103 +/- 4 mm Hg) was the only parameter that was significantly different in the cecal ligation-perforation plus pentoxifylline group compared with controls. When compared with controls, tissue wet/dry weight ratios were increased in the diaphragm of the cecal ligation-perforation group and in the liver, pancreas, small bowel, and large bowel of the cecal ligation-perforation, and the cecal ligation-perforation plus pentoxifylline groups. Tissue/plasma albumin ratios were increased in the diaphragm of the cecal ligation-perforation group and in the liver, pancreas, and large bowel of the cecal ligation-perforation and the cecal ligation-perforation plus pentoxifylline groups. There were no significant differences between the cecal ligation-perforation and the cecal ligation-perforation plus pentoxifylline groups. Normotensive sepsis is accompanied by increased vascular permeability in the diaphragm and intra-abdominal organs. Pentoxifylline appears to attenuate some of the systemic manifestations of sepsis. However, pentoxifylline did not prevent the development of protein-rich tissue edema.Keywords
This publication has 15 references indexed in Scilit:
- Differential Impairment of Vascular Reactivity of Small Pulmonary and Systemic Arteries in Hyperdynamic SepsisAmerican Review of Respiratory Disease, 1993
- The Pathogenesis of SepsisAnnals of Internal Medicine, 1991
- Lung fluid dynamics and supply dependency of oxygen uptake during experimental endotoxic shock and volume resuscitationCritical Care Medicine, 1991
- Evidence for Tumor Necrosis Factor-induced Pulmonary Microvascular Injury After Intestinal Ischemia—Reperfusion InjuryAnnals of Surgery, 1990
- A unifying hypothesis of multiple systems organ failure: Failure of host defense homeostasisJournal of Critical Care, 1990
- The Effects of Aminophylline and Pentoxifylline on Multiple Organ Damage afterEscherichia coliSepsisAmerican Review of Respiratory Disease, 1989
- Septic shock: the cardiovascular abnormality and therapyJournal of Cardiothoracic Anesthesia, 1989
- Pentoxifylline Decreases Endotoxin-induced Pulmonary Neutrophil Sequestration and Extravascular Protein Accumulation in the DogAmerican Review of Respiratory Disease, 1988
- Attenuation of Acute Lung Injury in Septic Guinea Pigs by PentoxifyllineAmerican Review of Respiratory Disease, 1988
- Pulmonary microvascular clearance of radiotracers in human cardiac and noncardiac pulmonary edemaJournal of Applied Physiology, 1981